Semler Scientific saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 85 to 95.
This exclusive rating from Investor's Business Daily tracks price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating at the beginning of a new climb.
Here Are 3 Keys For Successful Stock Investing
Semler Scientific has climbed more than 5% past a 29.93 entry in a first-stage cup with handle, meaning it's now out of a proper buy range. Look for the stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings grew 1% last quarter, up from -99% in the prior report. Revenue also increased, from -22% to -17%.
The company earns the No. 17 rank among its peers in the Medical-Products industry group. Insulet, LeMaitre Vascular and Pro-Dex are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
